Related references
Note: Only part of the references are listed.Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
Graca M. Dores et al.
BLOOD (2012)
Outcome of Adults With Acute Lymphocytic Leukemia After Second Salvage Therapy
Susan O'Brien et al.
CANCER (2008)
Pharmacokinetics and In Vivo Drug Release Rates in Liposomal Nanocarrier Development
Daryl C. Drummond et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
Concept and clinical evaluation of carrier-mediated anticancer agents
William C. Zamboni
ONCOLOGIST (2008)
Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin
Michael J. W. Johnston et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity
SQ Shan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations
MJW Johnston et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retention
IV Zhigaltsev et al.
JOURNAL OF CONTROLLED RELEASE (2005)
In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors
C Leonetti et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model
SE Holwell et al.
BRITISH JOURNAL OF CANCER (2001)
Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
